跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZORYVE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ZORYVE
Authorized
STANDARD
ZORYVE
arcutis canada, inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
735afb56bba1a738
Company
arcutis canada, inc.
Type
Standard
Approval Details
Approval Id
735afb56bba1a738
Drug Approval Canada Name
ZORYVE
Product Name
ZORYVE
Status
Marketed
Status Date
2025-04-29
Original Market Date
2023-06-02
Din
02537532
Drug Class
Human
Dosage Form
Cream
Route Of Administration
Topical
Schedule
Prescription
Ahfs
84:92.00
Atc Original
D05AX06 ROFLUMILAST
Atc Name
d 05 ax 06
Aig Number
0152826002
Company Name
arcutis canada, inc.
Company Address
5200 Yonge Street, 2nd Floor, North York, Ontario, Canada, M2N 5P6
Active Ingredients
ROFLUMILAST
0.3 % / W/W
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
735afb56bba1a738
Type
Standard
Back to Health Canada Approvals